SEC Filing Analysis: Adaptive Biotechnologies Corp (ADPT)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer at Adaptive Biotechnologies has filed a notice of a proposed sale of approximately $1.27 million worth of common stock under a pre-scheduled 10b5-1 trading plan.
• Market Impact: The transaction is considered routine and is expected to have a neutral to minimal impact on the stock, given its small size relative to the company's market capitalization and the pre-planned nature of the sale.

Company Information

Field	Value
Company	Adaptive Biotechnologies Corp
Ticker Symbol	ADPT
CIK	0001478320
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Chad Robins
CIK	0001780649
Title/Position	Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	144 (Notice of Proposed Sale)
Transaction Date	2025-11-10 (Approximate Sale Date)
Transaction Code	Not Applicable (Sale)
Security Type	Common Stock
Shares Involved	86,161
Price Per Share	~$14.71 (Calculated)
Total Value	$1,267,428.31
Shares Owned After	Not Disclosed
Ownership Type	Not Disclosed

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$1,267,428.31
% of Market Cap	0.056%
Shares Transacted	86,161
% of Shares Outstanding	0.057%
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The $1.27 million sale is a minor event for a company with a market capitalization of $2.26 billion. Such transactions are common for executive liquidity and compensation purposes.
• Transaction Significance: The sale is rated as low significance because it represents a negligible fraction (under 0.1%) of both the company's market value and its total shares outstanding.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is executed under a Rule 10b5-1 plan, indicating it was scheduled in advance and not based on recent material non-public information. The small size of the transaction further supports a neutral outlook.

Volume & Sentiment

• Expected Volume Impact: Minimal. The transaction size is unlikely to cause a noticeable impact on daily trading volume.
• Sentiment Indicator: Neutral. Pre-planned sales by executives are generally not viewed as bearish signals by the market.

Additional Context

Special Circumstances

• The filing explicitly states that the sale is made in connection with a Rule 10b5-1 selling plan adopted on August 11, 2025. This provides a structured, pre-planned method for insiders to sell shares without being accused of trading on inside information.